Compare NUVB & ATHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | ATHM |
|---|---|---|
| Founded | 2018 | 2008 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | N/A | 2013 |
| Metric | NUVB | ATHM |
|---|---|---|
| Price | $5.89 | $19.14 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | $11.44 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 4.0M | 447.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.97% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $659.84 | N/A |
| Revenue Next Year | $180.43 | $1.20 |
| P/E Ratio | ★ N/A | $12.13 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.57 | $19.50 |
| 52 Week High | $9.75 | $31.40 |
| Indicator | NUVB | ATHM |
|---|---|---|
| Relative Strength Index (RSI) | 48.93 | 24.01 |
| Support Level | $5.12 | N/A |
| Resistance Level | $6.22 | $23.60 |
| Average True Range (ATR) | 0.33 | 0.67 |
| MACD | 0.09 | -0.12 |
| Stochastic Oscillator | 77.97 | 1.83 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.